[May drugs be a cost-effective investment in Spanish health system?].
Soto
J
J
Departamento de Medicina, Pharmacia S.A, Barcelona, Spain. javier.soto.alvarez@pharmacia.com
Olivella
P
P
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D009313:National Health Programs / Q000191:economics*; D013030:Spain